Zobrazeno 1 - 10 of 108 pro vyhledávání: '"Josef Dirschinger"'
1
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial
Autor: Gert Richardt, Melchior Seyfarth, Josef Dirschinger, Peter B. Berger, Ahmed A. Khattab, Gjin Ndrepepa, Heinz Joachim Büttner, Stefanie Schulz, Albert Schömig, Jürgen Pache, Julinda Mehilli, Franz-Josef Neumann, Adnan Kastrati
Publikováno v: Khattab, Ahmed Aziz; Ndrepepa, Gjin; Schulz, Stefanie; Neumann, Franz-Josef; Mehilli, Julinda; Büttner, Heinz Joachim; Pache, Jürgen; Seyfarth, Melchior; Dirschinger, Josef; Kastrati, Adnan; Berger, Peter B.; Schömig, Albert; Richardt, Gert (2011). Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial. Clinical research in cardiology, 100(7), pp. 579-585. Springer-Verlag 10.1007/s00392-011-0282-7
Objective: To determine whether statin therapy influences the efficacy of thrombin inhibitor bivalirudin or unfractionated heparin (UFH) during PCI. Setting and patients: The post-hoc analysis of the ISAR-REACT 3 Trial included 4,570 patients: 3,106
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f82f57942cb48e3649754702cac59b9
https://doi.org/10.1007/s00392-011-0282-7
Zobrazit plný text záznamu
2
Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Autor: Stefanie Schulz, Karl-Ludwig Laugwitz, Steffen Massberg, Albert Schömig, Julinda Mehilli, Josef Dirschinger, Stefanie Fichtner, Steffan Martinoff, Ilka Ott, Martin Hadamitzky, Adnan Kastrati, Markus Schwaiger, Tareq Ibrahim, Katharina Hoppe
Publikováno v: Circulation: Cardiovascular Interventions. 3:408-413
Background— Erythropoietin improves myocardial function in experimental models of myocardial infarction. The aim of the present study was to determine the value of erythropoietin in patients with acute ST-elevation myocardial infarction. Methods an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6127984348c71118ea285862a3fc0e
https://doi.org/10.1161/circinterventions.109.904425
Zobrazit plný text záznamu
3
Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease
Autor: Isar-Left-Main (Intracoronary Stenting), Steffen Maßberg, Jürgen Pache, Olga Bruskina, Albert Schömig, Karl-Ludwig Laugwitz, Stefanie Schulz, Raisuke Iijima, Adnan Kastrati, Julinda Mehilli, Melchior Seyfarth, Josef Dirschinger, Robert A. Byrne
Publikováno v: Journal of the American College of Cardiology. 53:1760-1768
Objectives The aim of this trial was to compare the safety and efficacy of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) for treatment of unprotected left main coronary artery (uLMCA) disease. Background Both PES and SES have red
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f50d2fee4272a3d3fe713b6d224167
https://doi.org/10.1016/j.jacc.2009.01.035
Zobrazit plný text záznamu
4
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading
Autor: Stefan Früngel, Franz Dotzer, Adnan Kastrati, Jürgen Pache, Albert Schömig, Markus Schwaiger, Melchior Seyfarth, Josef Dirschinger, Kurt Huber, Stefan Martinoff, Stefanie Schulz, Stephan G. Nekolla, Werner Moshage, Julinda Mehilli
Publikováno v: Circulation. 119:1933-1940
Background— The glycoprotein IIb/IIIa receptor inhibitor abciximab has improved the efficacy of primary percutaneous coronary interventions in patients with acute myocardial infarction. However, it is not known whether abciximab remains beneficial
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606566ac0fd87fc9f77da87fb499b076
https://doi.org/10.1161/circulationaha.108.818617
Zobrazit plný text záznamu
5
Effect of Abciximab on Clinical and Angiographic Restenosis in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
Autor: Jürgen Pache, Albert Schömig, Gjin Ndrepepa, Melchior Seyfarth, Josef Dirschinger, Raisuke Iijima, Julinda Mehilli, Adnan Kastrati
Publikováno v: The American Journal of Cardiology. 101:1226-1231
The ISAR-REACT 2 trial was designed to assess the effect of abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after a 600-mg loading dose of clopidogrel. The aim of the present study was to investigate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f011ae7fd6cc4941454f44fa890caf
https://doi.org/10.1016/j.amjcard.2007.12.019
Zobrazit plný text záznamu
6
Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment
Autor: Julinda Mehilli, Josef Dirschinger, Stefanie Schulz, Adnan Kastrati, Albert Schömig, Gjin Ndrepepa, Raisuke Iijima, Olga Bruskina, Peter B. Berger, Jurriën M. ten Berg, Franz Dotzer, Franz-Josef Neumann
Publikováno v: Clinical Research in Cardiology. 97:160-168
We investigated how does troponin level (TnT) affect the benefit achieved by abciximab in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) after pretreatment with a high loading dose of clopidogrel. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33fb1c3ba03145ee104f5104c2d9578
https://doi.org/10.1007/s00392-007-0603-z
Zobrazit plný text záznamu
8
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents
Autor: Susanne Pinieck, Jürgen Pache, Albert Schömig, Josef Dirschinger, Adnan Kastrati, Alban Dibra, Sandra Mayer, Julinda Mehilli
Publikováno v: Circulation. 113:2293-2300
Background— The efficacy of drug-eluting stents in reducing restenosis risk has not been uniform across patient subsets. Identifying predictive factors of restenosis may help improve outcomes after percutaneous coronary interventions. Methods and R
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa95eeccbc20bd8255d93b8b057f703
https://doi.org/10.1161/circulationaha.105.601823
Zobrazit plný text záznamu
9
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels
Autor: Adnan Kastrati, Julinda Mehilli, Albert Schömig, Josef Dirschinger, Jürgen Pache, Alban Dibra
Publikováno v: European Heart Journal. 27:260-266
Sirolimus- and paclitaxel-eluting stents effectively reduce restenosis in small coronary vessels. The relative efficacy of these drug-eluting stents in this high-risk subset is not known.A total of 360 patients undergoing percutaneous coronary interv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a103cb38552542ae8c3fff69002306
https://doi.org/10.1093/eurheartj/ehi721
Zobrazit plný text záznamu
10
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting
Autor: Julinda Mehilli, Helmut Schühlen, Siegmund Braun, Hannsjörg Baum, Albert Schömig, Martin Hadamitzky, Alban Dibra, Josef Dirschinger, Adnan Kastrati
Publikováno v: American Heart Journal. 150:344-350
Objectives We hypothesized that a higher degree of inflammatory response to coronary stenting, as measured by the change in C-reactive protein (CRP) levels after intervention in patients with stable or unstable angina, would be related to a higher ri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3b6e7ea5e53e14d12bc8e5343bead1
https://doi.org/10.1016/j.ahj.2004.09.030
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje